Solmux is a long-established product line within the UNILAB portfolio. Current company information indicates the brand has existed for more than 30 years. Records from the Philippine Food and Drug Administration (FDA) show that the 500-mg Solmux capsule was authorized by 2005, with several liquid formulations registered by 2011.[1][2]

The brand’s central medical ingredient is carbocisteine, which belongs to the mucolytic class. Rather than suppressing the cough reflex, carbocisteine acts directly on mucus to reduce viscosity, allowing thick and sticky phlegm to be expelled more easily.[2] This mechanism distinguishes Solmux from antitussives; it is principally intended for productive or “wet” coughs rather than dry coughs.

Carbocisteine is the active pharmaceutical ingredient in original Solmux products. Classified as a mucolytic agent, it addresses respiratory mucus that becomes unusually thick and difficult to clear during illness. By modifying the mucus structure, carbocisteine facilitates expulsion through coughing.[2]

According to Philippine FDA product information, carbocisteine is indicated for coughs characterized by excessive or sticky sputum. Approved uses include respiratory conditions such as acute bronchitis, chronic obstructive pulmonary disease (COPD), and otitis media with effusion.[2]

The therapeutic concept behind Solmux follows a specific pathway: thick phlegm is modified by carbocisteine, reducing its viscosity so that respiratory secretions can be cleared more effectively.

UNILAB markets this mechanism as a “lung-cleaning” action, emphasizing phlegm removal over cough suppression. Consumer information states that Solmux helps melt phlegm, making it less sticky and easier to expel.[1] This differentiates it from traditional cough suppressants that target the cough reflex itself.

The Solmux name encompasses several formulations tailored to different patient needs.

Solmux Capsule

The standard adult formulation is a 500-mg carbocisteine capsule. Listed among registered formulations by the Philippine FDA, it is intended for coughs associated with excessive or sticky phlegm.[2]

Solmux Syrup and Oral Drops

Liquid formulations are available for patients who cannot swallow capsules. FDA documentation lists the following strengths:[2]

• 40 mg/mL oral drops
• 100 mg/5 mL pediatric syrup
• 500 mg/5 mL Forte adult suspension
• 500-mg capsule

Pediatric variants are designed to facilitate administration for younger patients.

Solmux for Kids

Solmux for Kids targets children experiencing cough with phlegm. Current formulations include 40-mg/mL oral drops and pediatric syrups in 100-mg/5-mL or 200-mg/5-mL strengths.[1]

Certain liquid products utilize TasteRite, a UNILAB taste-masking technology intended to improve palatability. FDA product information describes these pediatric liquids as having a strawberry taste and odor.[2]

Solmux Advance

Solmux Advance combines carbocisteine with zinc. The tablet contains:[1]

• Carbocisteine — 500 mg
• Elemental zinc — 5 mg

This formulation treats cough with phlegm while highlighting zinc’s role in immune function.[1] A Solmux Advance Suspension is also available, containing carbocisteine and zinc with added menthol for throat soothing.[1]

Solmux Broncho

Solmux Broncho differs from standard Solmux products by combining salbutamol and carbocisteine. Each capsule contains:[1]

• Salbutamol — 2 mg
• Carbocisteine — 500 mg

It is a prescription medicine indicated for the symptomatic treatment of productive cough associated with airway disorders such as acute or chronic bronchitis, bronchial asthma, and bronchiectasis.[1] Unlike over-the-counter Solmux variants, Solmux Broncho contains a bronchodilator and requires a prescription.

Solmux and carbocisteine products are primarily indicated for productive cough, particularly when sputum is excessive, thick, or sticky. Philippine FDA information lists the following respiratory conditions:[2]

• Acute bronchitis
• Chronic obstructive pulmonary disease (COPD)
• Other respiratory disorders involving excessive or sticky sputum
• Otitis media with effusion (“glue ear”) in appropriate medical contexts

Solmux is not indicated for all cough types. UNILAB advises individuals with dry or allergic coughs to consult a doctor, as these may require different treatments.[1]

While generally well-tolerated, carbocisteine may cause adverse effects. Philippine FDA product information identifies nausea, stomach discomfort, diarrhea, and skin rashes as common undesirable effects.[2]

Carbocisteine is typically contraindicated for individuals with an active stomach or intestinal ulcer or known hypersensitivity to the medicine or its excipients.[2]

Dosage and formulation depend on age and medical condition. Professional medical advice is recommended for pregnancy, breastfeeding, potential drug interactions, or persistent symptoms. UNILAB specifically advises consulting a doctor regarding use during pregnancy or lactation.[1]

Solmux is part of the portfolio of UNILAB, Inc., a major Philippine pharmaceutical company. Certain Solmux products are manufactured by Amherst Laboratories, Inc. at the UNILAB Pharma Campus in Biñan, Laguna.[2]

UNILAB has developed proprietary technologies used in the Solmux line, including ZincPlus Technology for Solmux Advance Tablet and TasteRite for pediatric medicines.[1]

Solmux is positioned as a medicine for cough with phlegm that facilitates expulsion. Communications consistently emphasize phlegm removal, respiratory clearance, and “lung cleaning.”[1]

UNILAB has extended this positioning across various consumer segments:

• Adults: Solmux Capsule and liquid formulations
• Children: Solmux for Kids
• Cough plus immune support: Solmux Advance
• Cough with bronchospasm/airway disease: Solmux Broncho (prescription only)
• Throat symptoms: Solmux Throat Spray

This strategy has established Solmux as a broader respiratory-health brand family rather than a single product.

Solmux products are widely distributed through Philippine pharmacies, drugstores, and online retailers nationwide.[1] Availability and purchasing requirements vary by regulatory classification; Solmux Broncho is a prescription drug, whereas other carbocisteine formulations are marketed as non-prescription medicines.[1]

Solmux holds significant market presence due to the strong association between the brand name and carbocisteine. UNILAB cites IQVIA data identifying it as the No. 1 carbocisteine brand in the Philippines.[1] Its longevity and expansion from a legacy capsule into pediatric, combination, and prescription respiratory medicines distinguish it within the local pharmaceutical landscape.

Note: This article provides a brand overview and does not constitute medical advice. Appropriate product selection depends on cough type, age, medical condition, and formulation. Users should follow product labeling or consult a healthcare professional.

1. Everything You Need to Know About Solmux Advance
2. Carbocisteine Solmux®